ARROWHEAD PHARMACEUTICALS, INC. Current Liabilities
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Current Liabilities of $283.35 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Liabilities, Current $283.35M.
- 2026-03-31: Liabilities, Current $295.22M.
- 2025-12-31: Liabilities, Current $347.43M.
- 2025-09-30: Liabilities, Current $195.49M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $283.35M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $295.22M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $347.43M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $195.49M 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $194.53M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $220.54M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $93.76M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $103.17M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $96.71M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $65.17M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $63.72M 10-Q · filed 2024-02-06 | |
| 2023-09-30 | $105.46M 10-K · filed 2024-11-26 | |
| 2023-06-30 | $70.23M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $87.15M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $122.01M 10-Q · filed 2023-02-06 | |
| 2022-09-30 | $138.85M 10-K · filed 2023-11-29 | |
| 2022-06-30 | $128.21M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $138.86M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $137.03M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $146.54M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $195.43M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $167.19M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $25.09M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $40.68M 10-K · filed 2021-11-22 | $40.68M 10-K · filed 2020-11-23 |
| 2020-06-30 | $42.78M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $53.33M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $73.70M 10-Q · filed 2020-02-05 | |
| 2019-09-30 | $97.07M 10-K · filed 2020-11-23 | |
| 2019-06-30 | $87.09M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $101.81M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $134.61M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $12.36M 10-K · filed 2019-11-25 | |
| 2018-06-30 | $7.13M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $9.12M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $13.72M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $18.70M 10-K · filed 2018-12-11 | |
| 2017-06-30 | $20.32M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $27.55M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $37.00M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $25.64M 10-K · filed 2017-12-12 | |
| 2016-06-30 | $14.84M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $14.06M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $12.33M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $15.90M 10-K · filed 2016-12-14 | |
| 2015-06-30 | $9.53M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $13.21M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $11.50M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $11.85M 10-K · filed 2015-12-14 | |
| 2014-06-30 | $8.25M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $10.48M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $9.02M 10-Q · filed 2014-02-04 | |
| 2013-09-30 | $8.73M 10-K · filed 2014-11-25 | |
| 2013-06-30 | $6.68M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $7.16M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $6.08M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $5.33M 10-K · filed 2013-12-18 | |
| 2012-06-30 | $5.82M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $6.38M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $5.06M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $2.58M 10-K · filed 2012-12-28 | |
| 2011-06-30 | $2.16M 10-Q · filed 2011-08-08 | |
| 2010-09-30 | $4.28M 10-K · filed 2011-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |